1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Generic Anti-cancer Injectables Market Size 2017-2028 2.1.2 Generic Anti-cancer Injectables Market Size CAGR by Region 2017 VS 2022 VS 2028 2.2 Generic Anti-cancer Injectables Segment by Type 2.2.1 Bevacizuma 2.2.2 Rituximab 2.2.3 Herceptin 2.2.4 Paclitaxel 2.2.5 Others 2.3 Generic Anti-cancer Injectables Market Size by Type 2.3.1 Generic Anti-cancer Injectables Market Size CAGR by Type (2017 VS 2022 VS 2028) 2.3.2 Global Generic Anti-cancer Injectables Market Size Market Share by Type (2017-2022) 2.4 Generic Anti-cancer Injectables Segment by Channel 2.4.1 Hospital 2.4.2 Retail 2.5 Generic Anti-cancer Injectables Market Size by Channel 2.5.1 Generic Anti-cancer Injectables Market Size CAGR by Channel (2017 VS 2022 VS 2028) 2.5.2 Global Generic Anti-cancer Injectables Market Size Market Share by Channel (2017-2022) 3 Generic Anti-cancer Injectables Market Size by Player 3.1 Generic Anti-cancer Injectables Market Size Market Share by Players 3.1.1 Global Generic Anti-cancer Injectables Revenue by Players (2020-2022) 3.1.2 Global Generic Anti-cancer Injectables Revenue Market Share by Players (2020-2022) 3.2 Global Generic Anti-cancer Injectables Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Generic Anti-cancer Injectables by Regions 4.1 Generic Anti-cancer Injectables Market Size by Regions (2017-2022) 4.2 Americas Generic Anti-cancer Injectables Market Size Growth (2017-2022) 4.3 APAC Generic Anti-cancer Injectables Market Size Growth (2017-2022) 4.4 Europe Generic Anti-cancer Injectables Market Size Growth (2017-2022) 4.5 Middle East & Africa Generic Anti-cancer Injectables Market Size Growth (2017-2022) 5 Americas 5.1 Americas Generic Anti-cancer Injectables Market Size by Country (2017-2022) 5.2 Americas Generic Anti-cancer Injectables Market Size by Type (2017-2022) 5.3 Americas Generic Anti-cancer Injectables Market Size by Channel (2017-2022) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Generic Anti-cancer Injectables Market Size by Region (2017-2022) 6.2 APAC Generic Anti-cancer Injectables Market Size by Type (2017-2022) 6.3 APAC Generic Anti-cancer Injectables Market Size by Channel (2017-2022) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Generic Anti-cancer Injectables by Country (2017-2022) 7.2 Europe Generic Anti-cancer Injectables Market Size by Type (2017-2022) 7.3 Europe Generic Anti-cancer Injectables Market Size by Channel (2017-2022) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Generic Anti-cancer Injectables by Region (2017-2022) 8.2 Middle East & Africa Generic Anti-cancer Injectables Market Size by Type (2017-2022) 8.3 Middle East & Africa Generic Anti-cancer Injectables Market Size by Channel (2017-2022) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Generic Anti-cancer Injectables Market Forecast 10.1 Global Generic Anti-cancer Injectables Forecast by Regions (2023-2028) 10.1.1 Global Generic Anti-cancer Injectables Forecast by Regions (2023-2028) 10.1.2 Americas Generic Anti-cancer Injectables Forecast 10.1.3 APAC Generic Anti-cancer Injectables Forecast 10.1.4 Europe Generic Anti-cancer Injectables Forecast 10.1.5 Middle East & Africa Generic Anti-cancer Injectables Forecast 10.2 Americas Generic Anti-cancer Injectables Forecast by Country (2023-2028) 10.2.1 United States Generic Anti-cancer Injectables Market Forecast 10.2.2 Canada Generic Anti-cancer Injectables Market Forecast 10.2.3 Mexico Generic Anti-cancer Injectables Market Forecast 10.2.4 Brazil Generic Anti-cancer Injectables Market Forecast 10.3 APAC Generic Anti-cancer Injectables Forecast by Region (2023-2028) 10.3.1 China Generic Anti-cancer Injectables Market Forecast 10.3.2 Japan Generic Anti-cancer Injectables Market Forecast 10.3.3 Korea Generic Anti-cancer Injectables Market Forecast 10.3.4 Southeast Asia Generic Anti-cancer Injectables Market Forecast 10.3.5 India Generic Anti-cancer Injectables Market Forecast 10.3.6 Australia Generic Anti-cancer Injectables Market Forecast 10.4 Europe Generic Anti-cancer Injectables Forecast by Country (2023-2028) 10.4.1 Germany Generic Anti-cancer Injectables Market Forecast 10.4.2 France Generic Anti-cancer Injectables Market Forecast 10.4.3 UK Generic Anti-cancer Injectables Market Forecast 10.4.4 Italy Generic Anti-cancer Injectables Market Forecast 10.4.5 Russia Generic Anti-cancer Injectables Market Forecast 10.5 Middle East & Africa Generic Anti-cancer Injectables Forecast by Region (2023-2028) 10.5.1 Egypt Generic Anti-cancer Injectables Market Forecast 10.5.2 South Africa Generic Anti-cancer Injectables Market Forecast 10.5.3 Israel Generic Anti-cancer Injectables Market Forecast 10.5.4 Turkey Generic Anti-cancer Injectables Market Forecast 10.5.5 GCC Countries Generic Anti-cancer Injectables Market Forecast 10.6 Global Generic Anti-cancer Injectables Forecast by Type (2023-2028) 10.7 Global Generic Anti-cancer Injectables Forecast by Channel (2023-2028) 11 Key Players Analysis 11.1 Teva 11.1.1 Teva Company Information 11.1.2 Teva Generic Anti-cancer Injectables Product Offered 11.1.3 Teva Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.1.4 Teva Main Business Overview 11.1.5 Teva Latest Developments 11.2 Viatris 11.2.1 Viatris Company Information 11.2.2 Viatris Generic Anti-cancer Injectables Product Offered 11.2.3 Viatris Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.2.4 Viatris Main Business Overview 11.2.5 Viatris Latest Developments 11.3 Biocon 11.3.1 Biocon Company Information 11.3.2 Biocon Generic Anti-cancer Injectables Product Offered 11.3.3 Biocon Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.3.4 Biocon Main Business Overview 11.3.5 Biocon Latest Developments 11.4 Amgen 11.4.1 Amgen Company Information 11.4.2 Amgen Generic Anti-cancer Injectables Product Offered 11.4.3 Amgen Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.4.4 Amgen Main Business Overview 11.4.5 Amgen Latest Developments 11.5 Sandoz (Novartis) 11.5.1 Sandoz (Novartis) Company Information 11.5.2 Sandoz (Novartis) Generic Anti-cancer Injectables Product Offered 11.5.3 Sandoz (Novartis) Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.5.4 Sandoz (Novartis) Main Business Overview 11.5.5 Sandoz (Novartis) Latest Developments 11.6 Pfizer 11.6.1 Pfizer Company Information 11.6.2 Pfizer Generic Anti-cancer Injectables Product Offered 11.6.3 Pfizer Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.6.4 Pfizer Main Business Overview 11.6.5 Pfizer Latest Developments 11.7 Qilu Pharmaceutical 11.7.1 Qilu Pharmaceutical Company Information 11.7.2 Qilu Pharmaceutical Generic Anti-cancer Injectables Product Offered 11.7.3 Qilu Pharmaceutical Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.7.4 Qilu Pharmaceutical Main Business Overview 11.7.5 Qilu Pharmaceutical Latest Developments 11.8 Jiangsu Hansoh 11.8.1 Jiangsu Hansoh Company Information 11.8.2 Jiangsu Hansoh Generic Anti-cancer Injectables Product Offered 11.8.3 Jiangsu Hansoh Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.8.4 Jiangsu Hansoh Main Business Overview 11.8.5 Jiangsu Hansoh Latest Developments 11.9 CTTQ 11.9.1 CTTQ Company Information 11.9.2 CTTQ Generic Anti-cancer Injectables Product Offered 11.9.3 CTTQ Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.9.4 CTTQ Main Business Overview 11.9.5 CTTQ Latest Developments 11.10 Jiangsu Hengrui 11.10.1 Jiangsu Hengrui Company Information 11.10.2 Jiangsu Hengrui Generic Anti-cancer Injectables Product Offered 11.10.3 Jiangsu Hengrui Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.10.4 Jiangsu Hengrui Main Business Overview 11.10.5 Jiangsu Hengrui Latest Developments 11.11 CSPC 11.11.1 CSPC Company Information 11.11.2 CSPC Generic Anti-cancer Injectables Product Offered 11.11.3 CSPC Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.11.4 CSPC Main Business Overview 11.11.5 CSPC Latest Developments 11.12 Innovent Biologics 11.12.1 Innovent Biologics Company Information 11.12.2 Innovent Biologics Generic Anti-cancer Injectables Product Offered 11.12.3 Innovent Biologics Generic Anti-cancer Injectables Revenue, Gross Margin and Market Share (2020-2022) 11.12.4 Innovent Biologics Main Business Overview 11.12.5 Innovent Biologics Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Generic Anti-cancer Injectables Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions) Table 2. Major Players of Bevacizuma Table 3. Major Players of Rituximab Table 4. Major Players of Herceptin Table 5. Major Players of Paclitaxel Table 6. Major Players of Others Table 7. Generic Anti-cancer Injectables Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions) Table 8. Global Generic Anti-cancer Injectables Market Size by Type (2017-2022) & ($ Millions) Table 9. Global Generic Anti-cancer Injectables Market Size Market Share by Type (2017-2022) Table 10. Generic Anti-cancer Injectables Market Size CAGR by Channel (2017 VS 2022 VS 2028) & ($ Millions) Table 11. Global Generic Anti-cancer Injectables Market Size by Channel (2017-2022) & ($ Millions) Table 12. Global Generic Anti-cancer Injectables Market Size Market Share by Channel (2017-2022) Table 13. Global Generic Anti-cancer Injectables Revenue by Players (2020-2022) & ($ Millions) Table 14. Global Generic Anti-cancer Injectables Revenue Market Share by Player (2020-2022) Table 15. Generic Anti-cancer Injectables Key Players Head office and Products Offered Table 16. Generic Anti-cancer Injectables Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Generic Anti-cancer Injectables Market Size by Regions 2017-2022 & ($ Millions) Table 20. Global Generic Anti-cancer Injectables Market Size Market Share by Regions (2017-2022) Table 21. Americas Generic Anti-cancer Injectables Market Size by Country (2017-2022) & ($ Millions) Table 22. Americas Generic Anti-cancer Injectables Market Size Market Share by Country (2017-2022) Table 23. Americas Generic Anti-cancer Injectables Market Size by Type (2017-2022) & ($ Millions) Table 24. Americas Generic Anti-cancer Injectables Market Size Market Share by Type (2017-2022) Table 25. Americas Generic Anti-cancer Injectables Market Size by Channel (2017-2022) & ($ Millions) Table 26. Americas Generic Anti-cancer Injectables Market Size Market Share by Channel (2017-2022) Table 27. APAC Generic Anti-cancer Injectables Market Size by Region (2017-2022) & ($ Millions) Table 28. APAC Generic Anti-cancer Injectables Market Size Market Share by Region (2017-2022) Table 29. APAC Generic Anti-cancer Injectables Market Size by Type (2017-2022) & ($ Millions) Table 30. APAC Generic Anti-cancer Injectables Market Size Market Share by Type (2017-2022) Table 31. APAC Generic Anti-cancer Injectables Market Size by Channel (2017-2022) & ($ Millions) Table 32. APAC Generic Anti-cancer Injectables Market Size Market Share by Channel (2017-2022) Table 33. Europe Generic Anti-cancer Injectables Market Size by Country (2017-2022) & ($ Millions) Table 34. Europe Generic Anti-cancer Injectables Market Size Market Share by Country (2017-2022) Table 35. Europe Generic Anti-cancer Injectables Market Size by Type (2017-2022) & ($ Millions) Table 36. Europe Generic Anti-cancer Injectables Market Size Market Share by Type (2017-2022) Table 37. Europe Generic Anti-cancer Injectables Market Size by Channel (2017-2022) & ($ Millions) Table 38. Europe Generic Anti-cancer Injectables Market Size Market Share by Channel (2017-2022) Table 39. Middle East & Africa Generic Anti-cancer Injectables Market Size by Region (2017-2022) & ($ Millions) Table 40. Middle East & Africa Generic Anti-cancer Injectables Market Size Market Share by Region (2017-2022) Table 41. Middle East & Africa Generic Anti-cancer Injectables Market Size by Type (2017-2022) & ($ Millions) Table 42. Middle East & Africa Generic Anti-cancer Injectables Market Size Market Share by Type (2017-2022) Table 43. Middle East & Africa Generic Anti-cancer Injectables Market Size by Channel (2017-2022) & ($ Millions) Table 44. Middle East & Africa Generic Anti-cancer Injectables Market Size Market Share by Channel (2017-2022) Table 45. Key Market Drivers & Growth Opportunities of Generic Anti-cancer Injectables Table 46. Key Market Challenges & Risks of Generic Anti-cancer Injectables Table 47. Key Industry Trends of Generic Anti-cancer Injectables Table 48. Global Generic Anti-cancer Injectables Market Size Forecast by Regions (2023-2028) & ($ Millions) Table 49. Global Generic Anti-cancer Injectables Market Size Market Share Forecast by Regions (2023-2028) Table 50. Global Generic Anti-cancer Injectables Market Size Forecast by Type (2023-2028) & ($ Millions) Table 51. Global Generic Anti-cancer Injectables Market Size Market Share Forecast by Type (2023-2028) Table 52. Global Generic Anti-cancer Injectables Market Size Forecast by Channel (2023-2028) & ($ Millions) Table 53. Global Generic Anti-cancer Injectables Market Size Market Share Forecast by Channel (2023-2028) Table 54. Teva Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 55. Teva Generic Anti-cancer Injectables Product Offered Table 56. Teva Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 57. Teva Main Business Table 58. Teva Latest Developments Table 59. Viatris Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 60. Viatris Generic Anti-cancer Injectables Product Offered Table 61. Viatris Main Business Table 62. Viatris Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 63. Viatris Latest Developments Table 64. Biocon Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 65. Biocon Generic Anti-cancer Injectables Product Offered Table 66. Biocon Main Business Table 67. Biocon Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 68. Biocon Latest Developments Table 69. Amgen Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 70. Amgen Generic Anti-cancer Injectables Product Offered Table 71. Amgen Main Business Table 72. Amgen Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 73. Amgen Latest Developments Table 74. Sandoz (Novartis) Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 75. Sandoz (Novartis) Generic Anti-cancer Injectables Product Offered Table 76. Sandoz (Novartis) Main Business Table 77. Sandoz (Novartis) Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 78. Sandoz (Novartis) Latest Developments Table 79. Pfizer Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 80. Pfizer Generic Anti-cancer Injectables Product Offered Table 81. Pfizer Main Business Table 82. Pfizer Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 83. Pfizer Latest Developments Table 84. Qilu Pharmaceutical Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 85. Qilu Pharmaceutical Generic Anti-cancer Injectables Product Offered Table 86. Qilu Pharmaceutical Main Business Table 87. Qilu Pharmaceutical Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 88. Qilu Pharmaceutical Latest Developments Table 89. Jiangsu Hansoh Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 90. Jiangsu Hansoh Generic Anti-cancer Injectables Product Offered Table 91. Jiangsu Hansoh Main Business Table 92. Jiangsu Hansoh Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 93. Jiangsu Hansoh Latest Developments Table 94. CTTQ Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 95. CTTQ Generic Anti-cancer Injectables Product Offered Table 96. CTTQ Main Business Table 97. CTTQ Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 98. CTTQ Latest Developments Table 99. Jiangsu Hengrui Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 100. Jiangsu Hengrui Generic Anti-cancer Injectables Product Offered Table 101. Jiangsu Hengrui Main Business Table 102. Jiangsu Hengrui Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 103. Jiangsu Hengrui Latest Developments Table 104. CSPC Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 105. CSPC Generic Anti-cancer Injectables Product Offered Table 106. CSPC Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 107. CSPC Main Business Table 108. CSPC Latest Developments Table 109. Innovent Biologics Details, Company Type, Generic Anti-cancer Injectables Area Served and Its Competitors Table 110. Innovent Biologics Generic Anti-cancer Injectables Product Offered Table 111. Innovent Biologics Main Business Table 112. Innovent Biologics Generic Anti-cancer Injectables Revenue ($ million), Gross Margin and Market Share (2020-2022) Table 113. Innovent Biologics Latest Developments List of Figures Figure 1. Generic Anti-cancer Injectables Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Generic Anti-cancer Injectables Market Size Growth Rate 2017-2028 ($ Millions) Figure 6. Global Generic Anti-cancer Injectables Market Size Market Share by Type in 2021 Figure 7. Generic Anti-cancer Injectables in Hospital Figure 8. Global Generic Anti-cancer Injectables Market: Hospital (2017-2022) & ($ Millions) Figure 9. Generic Anti-cancer Injectables in Retail Figure 10. Global Generic Anti-cancer Injectables Market: Retail (2017-2022) & ($ Millions) Figure 11. Global Generic Anti-cancer Injectables Market Size Market Share by Channel in 2021 Figure 12. Global Generic Anti-cancer Injectables Revenue Market Share by Player in 2021 Figure 13. Global Generic Anti-cancer Injectables Market Size Market Share by Regions (2017-2022) Figure 14. Americas Generic Anti-cancer Injectables Market Size 2017-2022 ($ Millions) Figure 15. APAC Generic Anti-cancer Injectables Market Size 2017-2022 ($ Millions) Figure 16. Europe Generic Anti-cancer Injectables Market Size 2017-2022 ($ Millions) Figure 17. Middle East & Africa Generic Anti-cancer Injectables Market Size 2017-2022 ($ Millions) Figure 18. Americas Generic Anti-cancer Injectables Value Market Share by Country in 2021 Figure 19. Americas Generic Anti-cancer Injectables Consumption Market Share by Type in 2021 Figure 20. Americas Generic Anti-cancer Injectables Market Size Market Share by Channel in 2021 Figure 21. United States Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 22. Canada Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 23. Mexico Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 24. Brazil Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 25. APAC Generic Anti-cancer Injectables Market Size Market Share by Region in 2021 Figure 26. APAC Generic Anti-cancer Injectables Market Size Market Share by Channel in 2021 Figure 27. China Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 28. Japan Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 29. Korea Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 30. Southeast Asia Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 31. India Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 32. Australia Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 33. Europe Generic Anti-cancer Injectables Market Size Market Share by Country in 2021 Figure 34. Europe Generic Anti-cancer Injectables Market Size Market Share by Type in 2021 Figure 35. Europe Generic Anti-cancer Injectables Market Size Market Share by Channel in 2021 Figure 36. Germany Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 37. France Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 38. UK Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 39. Italy Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 40. Russia Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 41. Middle East & Africa Generic Anti-cancer Injectables Market Size Market Share by Region in 2021 Figure 42. Middle East & Africa Generic Anti-cancer Injectables Market Size Market Share by Type in 2021 Figure 43. Middle East & Africa Generic Anti-cancer Injectables Market Size Market Share by Channel in 2021 Figure 44. Egypt Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 45. South Africa Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 46. Israel Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 47. Turkey Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 48. GCC Country Generic Anti-cancer Injectables Market Size Growth 2017-2022 ($ Millions) Figure 49. Americas Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 50. APAC Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 51. Europe Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 52. Middle East & Africa Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 53. United States Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 54. Canada Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 55. Mexico Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 56. Brazil Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 57. China Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 58. Japan Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 59. Korea Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 60. Southeast Asia Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 61. India Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 62. Australia Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 63. Germany Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 64. France Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 65. UK Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 66. Italy Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 67. Russia Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 68. Spain Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 69. Egypt Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 70. South Africa Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 71. Israel Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 72. Turkey Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions) Figure 73. GCC Countries Generic Anti-cancer Injectables Market Size 2023-2028 ($ Millions)